Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study

J. J. Kavanagh, M. W. Sill, P. T. Ramirez, D. Warshal, M. L. Pearl, M. A. Morgan, Denise Mackey

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study'. Together they form a unique fingerprint.

Medicine & Life Sciences